Candriam Equities L Biotech.C-H EUR Acc/ LU1120766206 /
| NAV2024-07-24 | Chg.-0.2600 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 216.2000EUR | -0.12% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 2024-07-25 | Public WebStation Live Factsheet | 2024 | English | - |
| 2024-06-03 | Prospectus | 2024 | English | 3,663.84 KB |
| 2024-06-03 | Prospectus | 2024 | German | 5,520.88 KB |
| 2024-03-01 | PRIIP Key Information Document | 2024 | German | 269.02 KB |
| 2023-12-31 | Account statment | 2023 | English | 5,416.37 KB |
| 2023-12-31 | Account statment | 2023 | German | 4,732.66 KB |
| 2023-06-30 | Semi-annual report | 2023 | English | 1,982.78 KB |
| 2023-06-30 | Semi-annual report | 2023 | German | 2,086.39 KB |
| 2022-12-01 | Key Investor Information | 2022 | German | 362.40 KB |
